Popular Keywords

Glomerulonephritis

Forms of Uveitis

Osteomalacia

Imaging

Epidemiology and clinical outcomes

Immunology

COVID-19 pandemic and celiac disease

Correspondence to Author: Gabril Samasca, 

Department of Immunology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

Abstract:

Background :
The global health has been impacted by the COVID-19 epidemic. Design : This review evaluated how people with celiac disease were affected by the COVID-19 pandemic. Results : During the COVID-19 pandemic, there was a surge in both the prevalence and complications of celiac disease. Since there is currently no recognized treatment for celiac disease other than a gluten detox, diet adherence is critical to the patient’s health and well-being. Conclusions : The therapy team should encourage and adopt a gluten-free diet for these patients.

Keywords : :  Coeliac disease,Incidence,COVID-19 ,Gluten-free diet Therapy ,Health education

INTRODUCTION :
Patients with celiac disease (CD) had a lot of trouble following a gluten abstinence regimen prior to the COVID-19 pandemic [1]. However, what took place amid the COVID-19 pandemic? Dermatitis and CD gluten-related diseases (GRDs) include herpetiformis (DH). A variety of intestinal and extraintestinal clinical manifestations are seen in both illnesses [2]. Five percent of the population had GRDs [3]. Recent years have seen a rise in the incidence of CD [4- 6], most likely as a result of better diagnoses. In addition, a genuine rise in this immune-based illness, unrelated to disease diagnosis, was the cause of the increase in incidence [5-8]. According to screening conducted in Israel between 2020 and 2021, the incidence of CD autoimmunity was four times higher in people aged 26 to 55 than it was in pediatric age groups, particularly in children 0–5. The prevalence of CD in the general population in the Asia-Pacific area was higher in women than in men, and it was higher in children than in adults (P < 0.05). [10]. Arab nations, including Saudi Arabia revealed that the general population had the highest CD prevalence (3.2%) and the lowest CD prevalence (0.1%) in Tunisia. Compared to men, women showed a higher prevalence of CD. The range of 1-3 years to 9-10 years was the peak age at diagnosis [11]. In the Uyghur Autonomous Region of Xinjiang, China, participants who lived in rural areas consumed more wheat than those who lived in urban areas (3.16% vs. 0.97%, P < 0.01), according to research on CD autoimmunity [12]. Women and children in Canada had the highest incidence of CD [13]. A UK study discovered a 5% incidence of CD seropositivity and 6%predominance of CDs. Compared to UK population estimates, these values were around five times higher [14]. There was no statistically significant increase in the prevalence of undiagnosed CD in Denmark over time, with a prevalence of 1.0% [15]. A study conducted in the USA linked increased latitude where the prevalence of CD based on serology is higher [16]. Between 2010 and 2017, 49 829 CD patients in the Swedish population had a marginally but statistically significantly elevated death risk [17].

Citation:

Gabril Samasca. COVID-19 pandemic and celiac disease. The Journal of Autoimmunity 2024.

Journal Info

  • Journal Name: The Journal of Autoimmunity
  • Impact Factor: 1.6*
  • ISSN: 3064-688X
  • DOI: 10.52338/tjoai
  • Short Name: TJOAI
  • Acceptance rate: 55%
  • Volume: 7 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days
  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility